Viatris

VTRS US Health Care Pharmaceuticals
S&P 500
$16.51
+0.79%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of -71.71.
  • Return on equity is healthy at 1,748.7%.
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Thin interest cover: operating profit covers interest only about -5.7 times.
  • Return on capital employed is on the lower side at -9.5%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
0.74

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Piotroski F-ScoreModerate
4 / 8

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 8 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$18.96B
Current Price$ 16.51
High / Low$ 18.39 / 9.43
Stock P/E-5.50
Book Value$ -0.17
Dividend Yield2.93%
ROCE-9.53%
ROE1748.71%
Debt to Equity-71.71
Current Ratio1.38
P/B Ratio1.3115666
EPS$ -3.00
Debt$14.41B
PAT Margin-24.67%
Cash PAT$-716.60M
ICR-5.65
Educational data only. Not a recommendation to buy, sell or hold any security.